Role of cytochrome P450–mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy

References

• Aarønaes M, Atar D, Bonarjee V, et al. (2007). [Congestive heart failure–etiology and diagnostic procedures]. Tidsskr Nor Laegeforen 127:171–173
   PubMedGoogle Scholar
• Aboutabl ME, Zordoky BN, El-Kadi AO. (2009). 3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats. Br J Pharmacol 158:1808–1819
   PubMed Web of Science ®Google Scholar
• Aboutabl ME, Zordoky BN, Hammock BD, El-Kadi AO. (2011). Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P450 induction by benzo(a) pyrene. J Cardiovasc Pharmacol 57:273–281
   PubMed Web of Science ®Google Scholar
• Ai D, Fu Y, Guo D, et al. (2007). Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci U S A 104:9018–9023
   PubMed Web of Science ®Google Scholar
• Ai D, Pang W, Li N, et al. (2009). Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci USA 106:564–569
   PubMed Web of Science ®Google Scholar
• Akbulut T, Regner KR, Roman RJ, et al. (2009). 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. Am J Physiol Renal Physiol 297:F662–F670
   Google Scholar
• Akki A, Zhang M, Murdoch C, et al. (2009). NADPH oxidase signaling and cardiac myocyte function. J Mol Cell Cardiol 47:15–22
   PubMed Web of Science ®Google Scholar
• Alonso-Galicia M, Maier KG, Greene AS, et al. (2002). Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283:R60–R68
   PubMed Web of Science ®Google Scholar
• Alsaad AM, Zordoky BN, El-Sherbeni AA, El-Kadi AO. (2012). Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats. Drug Metab Dispos 40:2126–2135
   PubMed Web of Science ®Google Scholar
• Andò S, Panno ML, Ciarcia G, et al. (1990). Plasma sex hormone concentrations during the reproductive cycle in the male lizard, Podarcis s. sicula. J Reprod Fertil 90:353–360
   PubMed Web of Science ®Google Scholar
• Anker SD, Chua TP, Ponikowski P, et al. (1997). Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96:526–534
   PubMed Web of Science ®Google Scholar
• Anrather J, Racchumi G, Iadecola C. (2006). NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281:5657–5667
   PubMed Web of Science ®Google Scholar
• Aoyagi T, Matsui T. (2011). Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des 17:1818–1824
   PubMed Web of Science ®Google Scholar
• Archer SL, Gragasin FS, Wu X, et al. (2003). Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation 107:769–776
   PubMed Web of Science ®Google Scholar
• Baldwin AS Jr. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649–683
   PubMed Web of Science ®Google Scholar
• Bao Y, Wang X, Li W, et al. (2011). 20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. J Cardiovasc Pharmacol 57:294–301
   PubMed Web of Science ®Google Scholar
• Barbosa-Sicard E, Markovic M, Honeck H, et al. (2005). Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem Biophys Res Commun 329:1275–1281
   PubMed Web of Science ®Google Scholar
• Batchu SN, Chaudhary KR, El-Sikhry H, et al. (2012). Role of PI3Ka and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection. J Mol Cell Cardiol 53:43–52
   PubMed Web of Science ®Google Scholar
• Batchu SN, Lee SB, Qadhi RS, et al. (2011). Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. Br J Pharmacol 162:897–907
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Weeks KL, Pretorius L, McMullen JR. (2010). Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Pharmacol Ther 128:191–227
   PubMed Web of Science ®Google Scholar
• Bertrand-Thiebault C, Ferrari L, Boutherin-Falson O, et al. (2004). Cytochromes P450 are differently expressed in normal and varicose human saphenous veins: Linkage with varicosis. Clin Exp Pharmacol Physiol 31:295–301
   PubMed Web of Science ®Google Scholar
• Bhatnagar A. (2004). Beating ischemia: A new feat of EETs? Circ Res 95:443–445
   PubMed Web of Science ®Google Scholar
• Bièche I, Narjoz C, Asselah T, et al. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731–742
   PubMed Web of Science ®Google Scholar
• Bodiga S, Gruenloh SK, Gao Y, et al. (2010). 20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt. Am J Physiol Lung Cell Mol Physiol 298:L564–L574
   PubMed Web of Science ®Google Scholar
• Bodiga S, Zhang R, Jacobs DE, et al. (2009). Protective actions of epoxyeicosatrienoic acid: Dual targeting of cardiovascular PI3K and KATP channels. J Mol Cell Cardiol 46:978–988
   PubMed Web of Science ®Google Scholar
• Bolz SS, Fisslthaler B, Pieperhoff S, et al. (2000). Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca(2+) changes and dilation in isolated resistance arteries. FASEB J 14:255–260
   PubMed Web of Science ®Google Scholar
• Braunwald E, Bristow MR. (2000). Congestive heart failure: Fifty years of progress. Circulation 102:IV14–IV23
   PubMed Web of Science ®Google Scholar
• Brauze D, Widerak M, Cwykiel J, et al. (2006). The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. Toxicol Lett 167:212–220
   PubMed Web of Science ®Google Scholar
• Bylund J, Bylund M, Oliw EH. (2001). cDna cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 280:892–897
   PubMed Web of Science ®Google Scholar
• Cambj-Sapunar L, Yu M, Harder DR, Roman RJ. (2003). Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34:1269–1275
   PubMed Web of Science ®Google Scholar
• Carreño JE, Apablaza F, Ocaranza MP, Jalil JE. (2006). [Cardiac hypertrophy: Molecular and cellular events]. Rev Esp Cardiol 59:473–486
   PubMed Web of Science ®Google Scholar
• Carroll MA, Balazy M, Margiotta P, et al. (1993). Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem 268:12260–12266
   PubMed Web of Science ®Google Scholar
• Carroll MA, Balazy M, Margiotta P, et al. (1996). Cytochrome P-450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides. Am J Physiol 271:R863–R869
   PubMed Web of Science ®Google Scholar
• Certíková Chábová V, Walkowska A, Kompanowska-Jezierska E, et al. (2010). Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats. Clin Sci 118:617–632
   PubMed Web of Science ®Google Scholar
• Chábová VC, Kramer HJ, Vanecková I, et al. (2007). Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Vascul Pharmacol 47:145–159
   PubMed Web of Science ®Google Scholar
• Chen D, Whitcomb R, MacIntyre E, et al. (2012). Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects. J Clin Pharmacol 52:319–328
   PubMed Web of Science ®Google Scholar
• Chen F, Castranova V, Shi X, Demers LM. (1999). New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 45:7–17
   PubMed Web of Science ®Google Scholar
• Chen Y, Medhora M, Falck JR, et al. (2006). Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 291:L378–L385
   PubMed Web of Science ®Google Scholar
• Cheng J, Wu CC, Gotlinger KH, et al. (2010). 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling. J Pharmacol Exp Ther 332:57–65
   PubMed Web of Science ®Google Scholar
• Cheranov SY, Karpurapu M, Wang D, et al. (2008). An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood 111:5581–5591
   PubMed Web of Science ®Google Scholar
• Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD. (2007). The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 50:225–237
   PubMed Web of Science ®Google Scholar
• Choudhary D, Jansson I, Schenkman JB, et al. (2003). Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. Arch Biochem Biophys 414:91–100
   PubMed Web of Science ®Google Scholar
• Choudhary D, Jansson I, Stoilov I, et al. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32:840–847
   PubMed Web of Science ®Google Scholar
• Choudhary D, Jansson I, Stoilov I, et al. (2005). Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch Biochem Biophys 436:50–61
   PubMed Web of Science ®Google Scholar
• Christmas P, Jones JP, Patten CJ, et al. (2001). Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J Biol Chem 276:38166–38172
   PubMed Web of Science ®Google Scholar
• Cowie MR, Wood DA, Coats AJ, et al. (1999). Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20:421–428
   PubMed Web of Science ®Google Scholar
• Crabtree GR Olson EN. (2002). NFAT signaling: Choreographing the social lives of cells. Cell 109:S67–S79
   PubMed Web of Science ®Google Scholar
• Crackower MA, Oudit GY, Kozieradzki I, et al. (2002). Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110:737–749
   PubMed Web of Science ®Google Scholar
• Croft KD, McGiff JC, Sanchez-Mendoza A, Carroll MA. (2000). Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 279:F544–F551
   PubMed Web of Science ®Google Scholar
• Cuez T, Korkmaz B, Buharalioglu CK, et al. (2010). A synthetic analogue of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension via increased 20-HETE levels associated with decreased iNOS protein expression and vasodilator prostanoid production in rats. Basic Clin Pharmacol Toxicol 106:378–388
   PubMed Web of Science ®Google Scholar
• Cui X, Nelson DR, Strobel HW. (2000). A novel human cytochrome P450 4F isoform (CYP4F11): cDNA cloning, expression, and genomic structural characterization. Genomics 68:161–166
   PubMed Web of Science ®Google Scholar
• Czekaj P, Wiaderkiewicz A, Florek E, Wiaderkiewicz R. (2000). Expression of cytochrome CYP2B1/2 in nonpregnant, pregnant and fetal rats exposed to tobacco smoke. Acta Biochimica Polonica 7:1115–1127
   Google Scholar
• Damås JK, Gullestad L, Aass H, et al. (2001). Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure–modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol 38:187–193
   PubMed Web of Science ®Google Scholar
• Davis BB, Morisseau C, Newman JW, et al. (2006). Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition. J Pharmacol Exp Ther 316:815–821
   PubMed Web of Science ®Google Scholar
• Davis BB, Thompson DA, Howard LL, et al. (2002). Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc Natl Acad Sci U S A 99:2222–2227
   PubMed Web of Science ®Google Scholar
• Delozier TC, Kissling GE, Coulter SJ, et al. (2007). Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35:682–688
   PubMed Web of Science ®Google Scholar
• Deng Y, Edin ML, Theken KN, et al. (2011). Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J 25:703–713
   PubMed Web of Science ®Google Scholar
• Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, et al. (2008). Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 294:H724–H735
   PubMed Web of Science ®Google Scholar
• Dollery CM, McEwan JR, Henney AM. (1995). Matrix metalloproteinases and cardiovascular disease. Circ Res 77:863–868
   PubMed Web of Science ®Google Scholar
• Dorn GW 2nd. (2009). Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81:465–473
   PubMed Web of Science ®Google Scholar
• Dorrance AM, Rupp N, Pollock DM, et al. (2005). An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 46:842–848
   PubMed Web of Science ®Google Scholar
• Dos Santos EA, Dahly-Vernon AJ, Hoagland KM, Roman RJ. (2004). Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. Am J Physiol Regul Integr Comp Physiol 287:R58–R68
   PubMed Web of Science ®Google Scholar
• Du G, Lv J, He L, Ma Y. (2011). Influence of silencing soluble epoxide hydrolase with RNA interference on cardiomyocytes apoptosis induced by doxorubicin. J Huazhong Univ Sci Technolog Med Sci 31:324–328
   PubMed Web of Science ®Google Scholar
• Dube P, Weber KT. (2011). Congestive heart failure: Pathophysiologic consequences of neurohormonal activation and the potential for recovery: Part I. Am J Med Sci 342:348–351
   PubMed Web of Science ®Google Scholar
• Dubey RK, Jackson EK, Gillespie DG, et al. (2005). Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab 90:247–255
   PubMed Web of Science ®Google Scholar
• Dubey RK, Jackson EK, Gillespie DG, et al. (2004). Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells. J Clin Endocrinol Metab 89:3922–3931
   PubMed Web of Science ®Google Scholar
• Dyck JR, Lopaschuk GD. (2006). AMPK alterations in cardiac physiology and pathology: Enemy or ally? J Physiol 574:95–112
   PubMed Web of Science ®Google Scholar
• Eiken HG, Øie E, Damås JK, et al. (2001). Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. European J Clin Invest 31:389–397
   PubMed Web of Science ®Google Scholar
• Enayetallah AE, French RA, Thibodeau MS, Grant DF. (2004). Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J Histochem Cytochem 52:447–454
   PubMed Web of Science ®Google Scholar
• Engels W, van Bilsen M, Wolffenbuttel BH, et al. (1999). Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat. Mol Cell Biochem 192:53–61
   PubMed Web of Science ®Google Scholar
• Escalante B, Falck JR, Yadagiri P, et al. (1988). 19(S)-hydroxyeicosatetraenoic acid is a potent stimulator of renal Na+-K+-ATPase. Biochem Biophys Res Commun 152:1269–1274
   PubMed Web of Science ®Google Scholar
• Etienne-Manneville S, Hall A. (2002). Rho GTPases in cell biology. Nature 420:629-635
   PubMed Web of Science ®Google Scholar
• Fagard RH. (1997). Impact of different sports and training on cardiac structure and function. Cardiol Clin 15:397–412
   PubMedGoogle Scholar
• Fang X, Kaduce TL, Weintraub NL, et al. (2001). Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem 276:14867–14874
   PubMed Web of Science ®Google Scholar
• Fang X, Kaduce TL, Weintraub NL, Spector AA. (1997). Cytochrome P450 metabolites of arachidonic acid: Rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. Prostaglandins Leukot Essent Fatty Acids 57:367–371
   PubMed Web of Science ®Google Scholar
• Fang X, Moore SA, Stoll LL, et al. (1998). 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. Am J Physiol 275:H2113–H2121
   PubMed Web of Science ®Google Scholar
• Fang X, Weintraub NL, Oltman CL, et al. (2002). Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. Am J Physiol Heart Circ Physiol 283:H2306–H2314
   PubMed Web of Science ®Google Scholar
• Fer M, Dréano Y, Lucas D, et al. (2008). Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 471:116–125
   PubMed Web of Science ®Google Scholar
• Filbrandt CR, Wu Z, Zlokovic B, et al. (2004). Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25:605–616
   PubMed Web of Science ®Google Scholar
• Fingar DC, Salama S, Tsou C, et al. (2002). Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16:1472–1487
   PubMed Web of Science ®Google Scholar
• Fisslthaler B, Popp R, Kiss L, et al. (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401:493–497
   PubMed Web of Science ®Google Scholar
• Fleming I. (2007). DiscrEET regulators of homeostasis: Epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Trends Pharmacol Sci 28:448–452
   PubMed Web of Science ®Google Scholar
• Flesch M, Höper A, Dell’Italia L, et al. (2003). Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 108:598–604
   PubMed Web of Science ®Google Scholar
• Fox KF, Cowie MR, Wood DA, et al. (2001). Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 22:228–236
   PubMed Web of Science ®Google Scholar
• Frenoux JM, Prost ED, Belleville JL, Prost JL. (2001). A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats. J Nutr 131:39–45
   PubMed Web of Science ®Google Scholar
• Frey N, Olson EN. (2003). Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol 65:45–79
   PubMed Web of Science ®Google Scholar
• Fulton D, Mahboubi K, McGiff JC, Quilley J. (1995). Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol 114:99–102
   PubMed Web of Science ®Google Scholar
• Galis ZS, Muszynski M, Sukhova GK, et al. (1994). Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181–189
   PubMed Web of Science ®Google Scholar
• García-Hoz C, Sánchez-Fernández G, García-Escudero R, et al. (2012). Protein kinase C (PKC)?-mediated Gaq stimulation of ERK5 protein pathway in cardiomyocytes and cardiac fibroblasts. J Biol Chem 287:7792–7802
   PubMed Web of Science ®Google Scholar
• Gebremedhin D, Harder DR, Pratt PF, Campbell WB. (1998). Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: Role of a cytochrome P450 metabolite. J Vasc Res 35:274–284
   PubMed Web of Science ®Google Scholar
• Gebremedhin D, Lange AR, Lowry TF, et al. (2000). Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87:60–65
   PubMed Web of Science ®Google Scholar
• Gebremedhin D, Ma YH, Falck JR, et al. (1992). Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 263:H519–H525
   PubMed Web of Science ®Google Scholar
• Geetha A, Marar T, Devi CS. (1991). Effect of alpha-tocopherol on doxorubicin-induced changes in rat liver and heart microsomes. Indian J Exp Biol 29:782–785
   PubMedGoogle Scholar
• Geng J, Zhao Z, Kang W, et al. (2009). Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cells. Biochem Biophys Res Commun 388:517–522
   PubMed Web of Science ®Google Scholar
• Gerdes AM. (2002). Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail 8:S264–S268
   PubMed Web of Science ®Google Scholar
• Ghosh S, May MJ, Kopp EB. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260
   PubMed Web of Science ®Google Scholar
• Glennon PE, Sugden PH, Poole-Wilson PA. (1995). Cellular mechanisms of cardiac hypertrophy. Br Heart J 73:496–499
   PubMedGoogle Scholar
• Gradman AH, Alfayoumi F. (2006). From left ventricular hypertrophy to congestive heart failure: Management of hypertensive heart disease. Prog Cardiovasc Dis 48:326–341
   PubMed Web of Science ®Google Scholar
• Granberg AL, Brunström B, Brandt I. (2000). Cytochrome P450-dependent binding of 7,12-dimethylbenz[a]anthracene (DMBA) and benzo[a]pyrene (B[a]P) in murine heart, lung, and liver endothelial cells. Arch Toxicol 74:593–601
   PubMed Web of Science ®Google Scholar
• Guo AM, Janic B, Sheng J, et al. (2011). The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: A regulator of endothelial precursor cells derived from human umbilical cord blood. J Pharmacol Exp Ther 338:421–429
   PubMed Web of Science ®Google Scholar
• Gutiérrez SH, Kuri MR, del Castillo ER. (2008). Cardiac role of the transcription factor NF-kappaB. Cardiovasc Hematol Disord Drug Targets 8:153–160
   PubMedGoogle Scholar
• Harder DR, Gebremedhin D, Narayanan J, et al. (1994). Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol 266:H2098–H2107
   PubMed Web of Science ®Google Scholar
• Hardwick JP, Song BJ, Huberman E, Gonzalez FJ. (1987). Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. J Biol Chem 262:801–810
   PubMed Web of Science ®Google Scholar
• Harmon SD, Fang X, Kaduce TL, et al. (2006). Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: Effect on 20-hydroxyeicosatetraenoic acid production. Prostaglandins Leukot Essent Fatty Acids 75:169–177
   PubMed Web of Science ®Google Scholar
• Harris TR, Li N, Chiamvimonvat N, Hammock BD. (2008). The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy. Congest Heart Fail 14:219–224
   PubMedGoogle Scholar
• Hecker M, Bara AT, Bauersachs J, Busse R. (1994). Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol 481:407–414
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Trogdon JG, Khavjou OA, et al; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Quality of Care and Outcomes Research. (2011). Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 123:933–944
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. (2006). Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589–600
   PubMed Web of Science ®Google Scholar
• Helvig C, Dishman E, Capdevila JH. (1998). Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. Biochemistry 37:12546–12558
   PubMed Web of Science ®Google Scholar
• Hercule HC Oyekan AO. (2000). Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am J Physiol Regul Integr Comp Physiol 279:R2132–R2141
   PubMed Web of Science ®Google Scholar
• Hill-Eubanks DC, Gomez MF, Stevenson AS, Nelson MT. (2003). NFAT regulation in smooth muscle. Trends Cardiovasc Med 13:56–62
   PubMed Web of Science ®Google Scholar
• Hiroi T, Imaoka S, Chow T, Funae Y. (1998). Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochimica Et Biophysica Acta 1380:305–312
   PubMed Web of Science ®Google Scholar
• Hirota H, Chen J, Betz UA, et al. (1999). Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97:189–198
   PubMed Web of Science ®Google Scholar
• Ho TJ, Huang CC, Huang CY, Lin WT. (2012). Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats. Eur J Appl Physiol 112:2943–2955
   PubMed Web of Science ®Google Scholar
• Ho YL, Wu CC, Lin LC, et al. (1998). Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with the dobutamine-atropine stress echocardiography: Effect of the left ventricular hypertrophy. Cardiology 89:52–58
   PubMed Web of Science ®Google Scholar
• Hoebel BG, Steyrer E, Graier WF. (1998). Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: More than just endothelium-derived hyperpolarizing factor? Clin Exp Pharmacol Physiol 25:826–830
   PubMed Web of Science ®Google Scholar
• Huang H, Morisseau C, Wang J, et al. (2007). Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats. Am J Physiol Renal Physiol 293:F342–F349
   PubMed Web of Science ®Google Scholar
• Hutchens MP, Nakano T, Dunlap J, et al. (2008). Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation. Resuscitation 76:89–94
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Aihara K, Sato T, et al. (2005). Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem 280:29661–29666
   PubMed Web of Science ®Google Scholar
• Imaoka S, Hashizume T, Funae Y. (2005). Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet 20:478–484
   PubMedGoogle Scholar
• Imig JD. (2005). Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 289:F496–F503
   PubMed Web of Science ®Google Scholar
• Imig JD. (2012). Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev 92:101–130
   PubMed Web of Science ®Google Scholar
• Imig JD, Navar LG, Roman RJ, et al. (1996a). Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7:2364–2370
   PubMed Web of Science ®Google Scholar
• Imig JD, Pham BT, LeBlanc EA, et al. (2000). Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension 35:307–312
   PubMed Web of Science ®Google Scholar
• Imig JD, Zhao X, Capdevila JH, et al. (2002). Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39:690–694
   PubMed Web of Science ®Google Scholar
• Imig JD, Zhao X, Zaharis CZ, et al. (2005). An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46:975–981
   PubMed Web of Science ®Google Scholar
• Imig JD, Zou AP, Stec DE, et al. (1996b). Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270:R217–R227
   PubMed Web of Science ®Google Scholar
• Inoue K, Sodhi K, Puri N, et al. (2009). Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am J Physiol Renal Physiol 297:F875–F884
   PubMed Web of Science ®Google Scholar
• Ishizuka T, Cheng J, Singh H, et al. (2008). 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells. J Pharmacol Exp Ther 324:103–110
   PubMed Web of Science ®Google Scholar
• Ito T, Suzuki T, Tamura K, et al. (2008). Examination of mRNA expression in rat hearts and lungs for analysis of effects of exposure to concentrated ambient particles on cardiovascular function. Toxicology 243:271–283
   PubMed Web of Science ®Google Scholar
• Jennings BL, Sahan-Firat S, Estes AM, et al. (2010). Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology. Hypertension 56:667–674
   PubMed Web of Science ®Google Scholar
• Jiang JG, Chen CL, Card JW, et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 65:4707–4715
   PubMed Web of Science ®Google Scholar
• Johansson C, Stark A, Sandberg M, et al. (1995). Tissue specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the mRNA levels in extrahepatic tissues and liver. Arch Toxicol 70:61–63
   PubMed Web of Science ®Google Scholar
• Kabe Y, Ando K, Hirao S, et al. (2005). Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7:395–403
   PubMed Web of Science ®Google Scholar
• Kacimi R, Gerdes AM. (2003). Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41:968–977
   PubMed Web of Science ®Google Scholar
• Kaduce TL, Fang X, Harmon SD, et al. (2004). 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. J Biol Chem 279:2648–2656
   PubMed Web of Science ®Google Scholar
• Karlgren M, Backlund M, Johansson I, et al. (2004). Characterization and tissue distribution of a novel human cytochrome P450-CYP2U1. Biochem Biophys Res Commun 315:679–685
   PubMed Web of Science ®Google Scholar
• Kaur S, Gill SS. (1985). Age-related changes in the activities of epoxide hydrolases in different tissues of mice. Drug Metab Dispos 13:711–715
   PubMed Web of Science ®Google Scholar
• Kauser K, Clark JE, Masters BS, et al. (1991). Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 68:1154–1163
   PubMed Web of Science ®Google Scholar
• Kerzee JK, Ramos KS. (2001). Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: Role of the Ahr bHLH/PAS transcription factor. Circ Res 89:573–582
   PubMed Web of Science ®Google Scholar
• Keserü B, Barbosa-Sicard E, Popp R, et al. (2008). Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J 22:4306–4315
   PubMed Web of Science ®Google Scholar
• Khairallah RJ, O’Shea KM, Brown BH, et al. (2010). Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium. J Pharmacol Exp Ther 335:155–162
   PubMed Web of Science ®Google Scholar
• Kikuta Y, Kusunose E, Endo K, et al. (1993). A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 268:9376–9380
   PubMed Web of Science ®Google Scholar
• Kimura S, Hanioka N, Matsunaga E, Gonzalez FJ. (1989). The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA 8:503–516
   PubMedGoogle Scholar
• Kompa, AR, Wang, BH, Xu, G, et al. (2012). Soluble epoxide hydrolase inhibition exerts beneficial anti-remodeling actions post-myocardial infarction. Int J Cardiol (Epub ahead of print)
   Google Scholar
• Konstantinidis K, Whelan RS, Kitsis RN. (2012). Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32:1552–1562
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Xu F. (2005). Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation. Annu Rev Pharmacol Toxicol 45:413–438
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Zeldin DC. (2002). Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 13:273–283
   PubMed Web of Science ®Google Scholar
• Kunert MP, Roman RJ, Alonso-Galicia M, et al. (2001). Cytochrome P-450 omega-hydroxylase: A potential O(2) sensor in rat arterioles and skeletal muscle cells. Am J Physiol Heart Circ Physiol 280:H1840–H1845
   PubMed Web of Science ®Google Scholar
• Kunisada K, Negoro S, Tone E, et al. (2000). Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 97:315–319
   PubMed Web of Science ®Google Scholar
• Kunisada K, Tone E, Fujio Y, et al. (1998). Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98:346–352
   Google Scholar
• Kuwahara K, Saito Y, Nakagawa O, et al. (1999). The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes-possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett 452:314–318
   PubMed Web of Science ®Google Scholar
• Laethem RM, Balazy M, Falck JR, et al. (1993). Formation of 19(S)-, 19®, and 18®-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem 268:12912–12918
   PubMed Web of Science ®Google Scholar
• Laethem RM, Halpert JR, Koop DR. (1994). Epoxidation of arachidonic acid as an active-site probe of cytochrome P-450 2B isoforms. Biochimica Et Biophysica Acta 1206:42–48
   PubMed Web of Science ®Google Scholar
• Larsen BT, Miura H, Hatoum OA, et al. (2006). Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: Implications for soluble epoxide hydrolase inhibition. Am J Physiol Heart Circ Physiol 290:H491–H499
   PubMed Web of Science ®Google Scholar
• Lasker JM, Chen WB, Wolf I, et al. (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem 275:4118–4126
   PubMed Web of Science ®Google Scholar
• Lauterbach B, Barbosa-Sicard E, Wang MH, et al. (2002). Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39:609–613
   PubMed Web of Science ®Google Scholar
• Lee HC, Lu T, Weintraub NL, et al. (1999). Effects of epoxyeicosatrienoic acids on the cardiac sodium channels in isolated rat ventricular myocytes. J Physiol 519:153–168
   PubMed Web of Science ®Google Scholar
• Levy D, Labib SB, Anderson KM, et al. (1990). Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81:815–820
   PubMed Web of Science ®Google Scholar
• Liang F, Gardner DG. (1999). Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. J Clin Invest 104:1603–1612
   PubMed Web of Science ®Google Scholar
• Liu CJ, Cheng YC, Lee KW, et al. (2008). Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Mol Cell Biochem 313:167–178
   PubMed Web of Science ®Google Scholar
• Liu J, Farmer JD Jr. Lane WS, et al. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807–815
   PubMed Web of Science ®Google Scholar
• Liu JY, Yang J, Inceoglu B, et al. (2010). Inhibition of soluble epoxide hydrolase enhances the antiinflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochem Pharmacol 79:880–887
   PubMed Web of Science ®Google Scholar
• Liu L, Chen C, Gong W, et al. (2011). Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther 339:451–463
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Schmelzer K, et al. (2005). The antiinflammatory effect of laminar flow: The role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci USA 102:16747–16752
   PubMed Web of Science ®Google Scholar
• Lu T, Hoshi T, Weintraub NL, et al. (2001). Activation of ATP-sensitive K(+) channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes. J Physiol 537:811–827
   PubMed Web of Science ®Google Scholar
• Luo G, Zeldin DC, Blaisdell JA, et al. (1998). Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 357:45–57
   PubMed Web of Science ®Google Scholar
• Lv X, Wan J, Yang J, et al. (2008). Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. Eur J Pharmacol 596:118–126
   PubMed Web of Science ®Google Scholar
• Ma J, Qu W, Scarborough PE, et al. (1999). Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem 274:17777–17788
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang L, Li S, et al. (2010). 8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway. Exp Cell Res 316:2340–2353
   PubMed Web of Science ®Google Scholar
• Ma YH, Gebremedhin D, Schwartzman ML, et al. (1993). 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72:126–136
   PubMed Web of Science ®Google Scholar
• Mallat Z, Heymes C, Corbaz A, et al. (2004). Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J 18:1752–1754
   PubMed Web of Science ®Google Scholar
• Mancy A, Dijols S, Poli S, et al. (1996). Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: Molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 35:16205–16212
   PubMed Web of Science ®Google Scholar
• Marino JP Jr. (2009). Soluble epoxide hydrolase, a target with multiple opportunities for cardiovascular drug discovery. Curr Top Med Chem 9:452–463
   PubMed Web of Science ®Google Scholar
• McCallum GP, Horton JE, Falkner KC, Bend JR. (1993). Microsomal cytochrome P450 1A1 dependent monooxygenase activity in guinea pig heart: Induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase. Can J Physiol Pharmacol 71:151–156
   PubMed Web of Science ®Google Scholar
• McLennan PL, Abeywardena MY, Dallimore JA, Raederstorff D. (2012). Dietary fish oil preserves cardiac function in the hypertrophied rat heart. Br J Nutr 108:645–654
   PubMed Web of Science ®Google Scholar
• McMullen JR, Amirahmadi F, Woodcock EA, et al. (2007). Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104:612–617
   PubMed Web of Science ®Google Scholar
• McMullen JR, Shioi T, Zhang L, et al. (2003). Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100:12355–12360
   PubMed Web of Science ®Google Scholar
• Medhora M, Narayanan J, Harder D, Maier KG. (2001). Identifying endothelium-derived hyperpolarizing factor: Recent approaches to assay the role of epoxyeicosatrienoic acids. Jpn J Pharmacol 86:369–375
   PubMedGoogle Scholar
• Meldrum DR. (1998). Tumor necrosis factor in the heart. Am J Physiol 274:R577–R595
   PubMed Web of Science ®Google Scholar
• Michaud V, Frappier M, Dumas MC, Turgeon J. (2010). Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism. Plos One 5:e15666
   PubMed Web of Science ®Google Scholar
• Minamiyama Y, Takemura S, Akiyama T, et al. (1999). Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels. FEBS Lett 452:165–169
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Verma IM. (1995). Rel/NF-kappa B/I kappa B story. Advances In Cancer Res 66:255–292
   PubMed Web of Science ®Google Scholar
• Miyata N, Seki T, Tanaka Y, et al. (2005). Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N′-hydroxyimido formamide], on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 314:77–85
   PubMed Web of Science ®Google Scholar
• Molkentin JD. (2004). Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467–475
   PubMed Web of Science ®Google Scholar
• Monti J, Fischer J, Paskas S, et al. (2008). Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat Genet 40:529–537
   PubMed Web of Science ®Google Scholar
• Moorthy B, Miller KP, Jiang W, et al. (2003). Role of cytochrome P4501B1 in benzo[a] pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: Evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. J Pharmacol Exp Ther 305:394–401
   PubMed Web of Science ®Google Scholar
• Moshal KS, Zeldin DC, Sithu SD, et al. (2008). Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. J Cell Physiol 215:771–781
   PubMed Web of Science ®Google Scholar
• Motoki A, Merkel MJ, Packwood WH, et al. (2008). Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Am J Physiol Heart Circ Physiol 295:H2128–H2134
   PubMed Web of Science ®Google Scholar
• Muslin AJ. (2005). Role of raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc Med 15:225–229
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Benter IF, Karzoun N, et al. (1998). 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95:12701–12706
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Benter IF, Khandekar Z, et al. (2000). Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 35:457–463
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Uddin MR, Fatima S, et al. (2001). Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells. Prostaglandins Other Lipid Mediat 65:33–43
   PubMed Web of Science ®Google Scholar
• Na W, Peng G, Jianping Z, et al. (2012). RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism. Toxicol Ind Health 28:831–839
   PubMed Web of Science ®Google Scholar
• Nadal-Ginard B, Kajstura J, Leri A, Anversa P. (2003). Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92:139–150
   PubMed Web of Science ®Google Scholar
• Naga Prasad SV, Esposito G, Mao L, et al. (2000). Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy. J Biol Chem 275:4693–4698
   PubMed Web of Science ®Google Scholar
• Nicol RL, Frey N, Pearson G, et al. (2001). Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20:2757–2767
   PubMedGoogle Scholar
• Nimnual AS, Yatsula BA, Bar-Sagi D. (1998). Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279:560–563
   PubMed Web of Science ®Google Scholar
• Nishida K, Kyoi S, Yamaguchi O, et al. (2009). The role of autophagy in the heart. Cell Death Differ 16:31–38
   PubMed Web of Science ®Google Scholar
• Nishikawa K, Yoshida M, Kusuhara M, et al. (2006). Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol 291:H176–H183
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, Brody DM, Tang AT, et al. (2010). Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists. Cancer Sci 101:2629–2636
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, DiCamelli RF, Kohler S, et al. (2001). Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem 292:115–124
   PubMed Web of Science ®Google Scholar
• Nithipatikom K, Gross ER, Endsley MP, et al. (2004). Inhibition of cytochrome P450 omega-hydroxylase: A novel endogenous cardioprotective pathway. Circ Res 95:e65–e71
   PubMed Web of Science ®Google Scholar
• Node K, Huo Y, Ruan X, et al. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276–1279
   PubMed Web of Science ®Google Scholar
• Norwood S, Liao J, Hammock BD, Yang GY. (2010). Epoxyeicosatrienoic acids and soluble epoxide hydrolase: Potential therapeutic targets for inflammation and its induced carcinogenesis. Am J Transl Res 2:447–457
   PubMed Web of Science ®Google Scholar
• Nowicki S, Chen SL, Aizman O, et al. (1997). 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+, K+-ATPase. J Clin Invest 99:1224–1230
   PubMed Web of Science ®Google Scholar
• Obara K, Koide M, Nakayama K. (2002). 20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel. Br J Pharmacol 137:1362–1370
   PubMed Web of Science ®Google Scholar
• Oesch F, Schladt L, Hartmann R, et al. (1986). Rat cytosolic epoxide hydrolase. Adv Exp Med Biol 197:195–201
   PubMedGoogle Scholar
• Omura T, Tanaka Y, Miyata N, et al. (2006). Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. Stroke 37:1307–1313
   PubMed Web of Science ®Google Scholar
• Oudit GY, Crackower MA, Eriksson U, et al. (2003). Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108:2147–2152
   PubMed Web of Science ®Google Scholar
• Oudit GY, Penninger JM. (2009). Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 82:250–260
   PubMed Web of Science ®Google Scholar
• Oyekan A, Balazy M, McGiff JC. (1997). Renal oxygenases: Differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol 273:R293–R300
   PubMed Web of Science ®Google Scholar
• Oyekan AO, McGiff JC. (1998). Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat. Am J Physiol 274:R52–R61
   PubMed Web of Science ®Google Scholar
• Palmer JN, Hartogensis WE, Patten M, et al. (1995). Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95:2555–2564
   PubMed Web of Science ®Google Scholar
• Pang W, Li N, Ai D, et al. (2011). Activation of peroxisome proliferator-activated receptor-? downregulates soluble epoxide hydrolase in cardiomyocytes. Clin Exp Pharmacol Physiol 38:358–364
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Edin ML, Lee CR, et al. (2012). Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest 122:178–191
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Greene ER, Pozzi A, et al. (2011). EET signaling in cancer. Cancer Metastasis Rev 30:525–540
   PubMed Web of Science ®Google Scholar
• Panigrahy D, Kaipainen A, Greene ER, Huang S. (2010). Cytochrome P450-derived eicosanoids: The neglected pathway in cancer. Cancer Metastasis Rev 29:723–735
   PubMed Web of Science ®Google Scholar
• Petrich BG, Eloff BC, Lerner DL, et al. (2004). Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem 279:15330–15338
   PubMed Web of Science ®Google Scholar
• Pokreisz P, Fleming I, Kiss L, et al. (2006). Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 47:762–770
   PubMed Web of Science ®Google Scholar
• Poloyac SM, Tortorici MA, Przychodzin DI, et al. (2004). The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney. Drug Metab Dispos 32:727–733
   PubMed Web of Science ®Google Scholar
• Pomposiello SI, Carroll MA, Falck JR, McGiff JC. (2001). Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR. Hypertension 37:887–893
   PubMed Web of Science ®Google Scholar
• Powell PK, Wolf I, Jin R, Lasker JM. (1998). Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285:1327–1336
   PubMed Web of Science ®Google Scholar
• Pozzi A, Macias-Perez I, Abair T, Wei S, et al. (2005). Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6-and 8,9-EET) as potent in vivo angiogenic lipids. J Biol Chem 280:27138–27146
   PubMed Web of Science ®Google Scholar
• Pratt PF, Li P, Hillard CJ, et al. (2001). Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol 280:H1113–H1121
   PubMed Web of Science ®Google Scholar
• Purcell NH, Tang G, Yu C, et al. (2001). Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA 98:6668–6673
   PubMed Web of Science ®Google Scholar
• Qu W, Bradbury JA, Tsao CC, et al. (2001). Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain. J Biol Chem 276:25467–25479
   PubMed Web of Science ®Google Scholar
• Quigley R, Baum M, Reddy KM, et al. (2000). Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am J Physiol Renal Physiol 278:F949–F953
   PubMed Web of Science ®Google Scholar
• Rahaman SO, Lennon DJ, Febbraio M, et al. (2006). A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4:211–221
   PubMed Web of Science ®Google Scholar
• Raman M, Chen W, Cobb MH. (2007). Differential regulation and properties of MAPKs. Oncogene 26:3100–3112
   PubMed Web of Science ®Google Scholar
• Randriamboavonjy V, Busse R, Fleming I. (2003). 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41:801–806
   PubMed Web of Science ®Google Scholar
• Renaud HJ, Cui JY, Khan M, Klaassen CD. (2011). Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice. Toxicol Sci 124:261–277
   PubMed Web of Science ®Google Scholar
• Renic M, Klaus JA, Omura T, et al. (2009). Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 29:629–639
   PubMed Web of Science ®Google Scholar
• Ricci R, Sumara G, Sumara I, et al. (2004). Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 306:1558–1561
   PubMed Web of Science ®Google Scholar
• Rifkind AB, Lee C, Chang TK, Waxman DJ. (1995). Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320:380–389
   PubMed Web of Science ®Google Scholar
• Ritter O, Neyses L. (2003). The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med 9:313–321
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Warne PH, Dhand R, et al. (1994). Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527–532
   PubMed Web of Science ®Google Scholar
• Roger VL. (2010). The heart failure epidemic. Int J Environ Res Public Health 7:1807–1830
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2012). Heart disease and stroke statistics–2012 update: A report from the American Heart Association. Circulation 125:e2–e220
   PubMed Web of Science ®Google Scholar
• Rohini A, Agrawal N, Koyani CN, Singh R. (2010). Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61:269–280
   PubMed Web of Science ®Google Scholar
• Rose BA, Force T, Wang Y. (2010). Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale. Physiol Rev 90:1507–1546
   PubMed Web of Science ®Google Scholar
• Sahai E, Marshall CJ. (2002). ROCK and Dia have opposing effects on adherens junctions downstream of Rho. Nat Cell Biol 4:408–415
   PubMedGoogle Scholar
• Sahan-Firat S, Jennings BL, Yaghini FA, et al. (2010). 2,3′,4,5′-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: Contribution of cytochrome P-450 1B1. Am J Physiol Heart Circ Physiol 299:H1891–H1901
   PubMed Web of Science ®Google Scholar
• Sanna B, Bueno OF, Dai YS, et al. (2005). Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase ½ signaling pathways regulate cardiac gene expression and cellular growth. Mol Cell Biol 25:865–878
   PubMed Web of Science ®Google Scholar
• Schladt L, Wörner W, Setiabudi F, Oesch F. (1986). Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats. Biochem Pharmacol 35:3309–3316
   PubMed Web of Science ®Google Scholar
• Schmelzer KR, Kubala L, Newman JW, et al. (2005). Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102:9772–9777
   PubMed Web of Science ®Google Scholar
• Schwartzman ML, Falck JR, Yadagiri P, Escalante B. (1989). Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem 264:11658–11662
   PubMed Web of Science ®Google Scholar
• See F, Thomas W, Way K, et al. (2004). p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 44:1679–1689
   PubMed Web of Science ®Google Scholar
• Sen R, Baltimore D. (1986). Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921–928
   PubMed Web of Science ®Google Scholar
• Seubert J, Yang B, Bradbury JA, et al. (2004). Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ Res 95:506–514
   PubMed Web of Science ®Google Scholar
• Seubert JM, Sinal CJ, Graves J, et al. (2006). Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ Res 99:442–450
   PubMed Web of Science ®Google Scholar
• Shimada T, Sugie A, Shindo M, et al. (2003). Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol Appl Pharmacol 187:1–10
   PubMed Web of Science ®Google Scholar
• Shioi T, Kang PM, Douglas PS, et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537–2548
   PubMed Web of Science ®Google Scholar
• Shioi T, McMullen JR, Kang PM, et al. (2002). Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol 22:2799–2809
   PubMed Web of Science ®Google Scholar
• Shiojima I, Sato K, Izumiya Y, et al. (2005). Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108–2118
   PubMed Web of Science ®Google Scholar
• Sidorik L, Kyyamova R, Bobyk V, et al. (2005). Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy. Cell Biol Int 29:51–55
   PubMed Web of Science ®Google Scholar
• Silverstein RL, Febbraio M. (2000). CD36 and atherosclerosis. Curr Opin Lipidol 11:483–491
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Miyata M, Tohkin M, et al. (2000). Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275:40504–40510
   PubMed Web of Science ®Google Scholar
• Singh H, Cheng J, Deng H, et al. (2007). Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 50:123–129
   PubMed Web of Science ®Google Scholar
• Smith KR, Pinkerton KE, Watanabe T. (2005). Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc Natl Acad Sci USA 102:2186–2191
   PubMed Web of Science ®Google Scholar
• Sodhi K, Wu CC, Cheng J, et al. (2010). CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent. Hypertension 56:871–878
   PubMed Web of Science ®Google Scholar
• Spearman ME, Prough RA, Estabrook RW, et al. (1985). Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch Biochem Biophys 242:225–230
   PubMed Web of Science ®Google Scholar
• Spector AA. (2009). Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 50:S52–S56
   PubMed Web of Science ®Google Scholar
• Stec DE, Gannon KP, Beaird JS, Drummond HA. (2007). 20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells. Cell Physiol Biochem 19:121–128
   PubMed Web of Science ®Google Scholar
• Stephens LR, Jackson TR, Hawkins PT. (1993). Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: A new intracellular signalling system? Biochimica Et Biophysica Acta 1179:27–75
   PubMed Web of Science ®Google Scholar
• Sugden PH. (2001). Mechanotransduction in cardiomyocyte hypertrophy. Circulation 103:1375–1377
   PubMed Web of Science ®Google Scholar
• Sun CW, Falck JR, Harder DR, Roman RJ. (1999). Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33:414–418
   PubMed Web of Science ®Google Scholar
• Tan FL, Moravec CS, Li J, et al. (2002). The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 99:11387–11392
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. (2000). Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005–L1028
   PubMed Web of Science ®Google Scholar
• Theken KN, Deng Y, Kannon MA, et al. (2011). Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. Drug Metab Dispos 39:22–29
   PubMed Web of Science ®Google Scholar
• Thompson CM, Capdevila JH, Strobel HW. (2000). Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exp Ther 294:1120–1130
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. (2000a). Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat. Br J Pharmacol 130:1745–1752
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. (2000b). Gene expression in distinct regions of the heart. Lancet 355:979–983
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. (2002). Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J 16:1537–1549
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, Kapadia S, Lee J, et al. (1996). Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
   PubMed Web of Science ®Google Scholar
• Tsakiridis T, Taha C, Grinstein S, Klip A. (1996). Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase. J Biol Chem 271:19664–19667
   PubMedGoogle Scholar
• Urano F, Wang X, Bertolotti A, et al. (2000). Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287:664–666
   PubMed Web of Science ®Google Scholar
• Valen G, Yan ZQ, Hansson GK. (2001). Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307–314
   PubMed Web of Science ®Google Scholar
• Van der Heiden K, Cuhlmann S, Luong leA, et al. (2010). Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci 118:593–605
   PubMed Web of Science ®Google Scholar
• VanRollins M. (1995). Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis. J Pharmacol Exp Ther 274:798–804
   PubMed Web of Science ®Google Scholar
• VanRollins M, Kaduce TL, Fang X, et al. (1996). Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem 271:14001–14009
   PubMed Web of Science ®Google Scholar
• VanRollins M, Kaduce TL, Knapp HR, Spector AA. (1993). 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res 34:1931–1942
   PubMed Web of Science ®Google Scholar
• Vatner DE, Yang GP, Geng YJ, et al. (2000). Determinants of the cardiomyopathic phenotype in chimeric mice overexpressing cardiac Gsalpha. Circ Res 86:802–806
   PubMed Web of Science ®Google Scholar
• Vazquez B, Rios A, Escalante B. (1995). Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci 56:1455–1466
   PubMed Web of Science ®Google Scholar
• Waechter F, Bentley P, Bieri F, et al. (1988). Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice. Biochem Pharmacol 37:3897–3903
   PubMed Web of Science ®Google Scholar
• Walker MK, Pollenz RS, Smith SM. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol Appl Pharmacol 143:407–419
   PubMed Web of Science ®Google Scholar
• Walles M, Thum T, Levsen K, Borlak J. (2002). Verapamil: New insight into the molecular mechanism of drug oxidation in the human heart. Journal Of Chromatography. A 970:117–130
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. (2012). Epoxyeicosatrienoic acids: A double-edged sword in cardiovascular diseases and cancer. J Clin Invest 122:19–22
   PubMed Web of Science ®Google Scholar
• Wang JS, Singh H, Zhang F, et al. (2006). Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 98:962–969
   PubMed Web of Science ®Google Scholar
• Wang P, Meijer J, Guengerich FP. (1982). Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme. Biochemistry 21:5769–5776
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang S, Sah VP, et al. (1998). Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273:2161–2168
   PubMed Web of Science ®Google Scholar
• Wang Y, Wei X, Xiao X, et al. (2005). Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther 314:522–532
   PubMed Web of Science ®Google Scholar
• Ward NC, Puddey IB, Hodgson JM, et al. (2005). Urinary 20-hydroxyeicosatetraenoic acid excretion is associated with oxidative stress in hypertensive subjects. Free Radic Biol Med 38:1032–1036
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG. (1993). Structural basis for pathologic left ventricular hypertrophy. Clin Cardiol 16:II10–II14
   PubMedGoogle Scholar
• Weintraub NL, Fang X, Kaduce TL, et al. (1997). Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ Res 81:258–267
   PubMed Web of Science ®Google Scholar
• Wencker D, Chandra M, Nguyen K, et al. (2003). A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497–1504
   PubMed Web of Science ®Google Scholar
• Westphal C, Konkel A, Schunck WH. (2011). CYP-eicosanoids-a new link between omega-3 fatty acids and cardiac disease? Prostaglandins Other Lipid Mediat 96:99–108
   PubMed Web of Science ®Google Scholar
• Widstrom RL, Norris AW, Spector AA. (2001). Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein. Biochemistry, 40:1070–1076
   PubMed Web of Science ®Google Scholar
• Wilkins BJ, Molkentin JD. (2004). Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322:1178–1191
   PubMed Web of Science ®Google Scholar
• Williams JM, Sarkis A, Lopez B, et al. (2007). Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis. Hypertension 49:687–694
   PubMed Web of Science ®Google Scholar
• Wong ET, Tergaonkar V. (2009). Roles of NF-kappaB in health and disease: Mechanisms and therapeutic potential. Clin Sci 116:451–465
   PubMed Web of Science ®Google Scholar
• Wong PY, Lai PS, Falck JR. (2000). Mechanism and signal transduction of 14®, 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Mediat 62:321–333
   PubMed Web of Science ®Google Scholar
• Wong PY, Lai PS, Shen SY, et al. (1997). Post-receptor signal transduction and regulation of 14®, 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J Lipid Mediat Cell Signal 16:155–169
   PubMedGoogle Scholar
• Wu S, Chen W, Murphy E, et al. (1997). Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272:12551–12559
   PubMed Web of Science ®Google Scholar
• Wu S, Moomaw CR, Tomer KB, et al. (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460–3468
   PubMed Web of Science ®Google Scholar
• Xu D, Li N, He Y, et al. (2006). Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103:18733–18738
   PubMed Web of Science ®Google Scholar
• Yaghi A, Sims SM. (2005). Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol 289:L1061–L1074
   PubMed Web of Science ®Google Scholar
• Yamada H, Kaneko H, Takeuchi K, et al. (1992). Tissue-specific expression, induction, and inhibition through metabolic intermediate-complex formation of guinea pig cytochrome P450 belonging to the CYP2B subfamily. Arch Biochem Biophys 299:248–254
   PubMed Web of Science ®Google Scholar
• Yamauchi-Takihara K, Kishimoto T. (2000). A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 10:298–303
   PubMed Web of Science ®Google Scholar
• Yanazume T, Hasegawa K, Wada H, et al. (2002). Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J Biol Chem 277:8618–8625
   PubMed Web of Science ®Google Scholar
• Yang B, Graham L, Dikalov S, et al. (2001). Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Molecular Pharmacology 60:310–320
   PubMed Web of Science ®Google Scholar
• Yang S, Lin L, Chen JX, et al. (2007). Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways. Am J Physiol Heart Circ Physiol 293:H142–H151
   PubMed Web of Science ®Google Scholar
• Yousif MH, Benter IF, Roman RJ. (2009). Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. Auton Autacoid Pharmacol 29:33–41
   PubMedGoogle Scholar
• Yu W, Chen L, Yang YQ, et al. (2011). Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemother Pharmacol 68:619–629
   PubMed Web of Science ®Google Scholar
• Yu Z, Davis BB, Morisseau C, et al. (2004). Vascular localization of soluble epoxide hydrolase in the human kidney. Am J Physiol Renal Physiol 286:F720–F726
   PubMed Web of Science ®Google Scholar
• Zeng Q, Han Y, Bao Y, et al. (2010). 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes. Am J Physiol Heart Circ Physiol 299:H1109–H1117
   PubMed Web of Science ®Google Scholar
• Zhang JY, Prakash C, Yamashita K, Blair IA. (1992). Regiospecific and enantioselective metabolism of 8,9-epoxyeicosatrienoic acid by cyclooxygenase. Biochem Biophys Res Commun 183:138–143
   PubMed Web of Science ®Google Scholar
• Zhang S, Weinheimer C, Courtois M, et al. (2003). The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest 111:833–841
   PubMed Web of Science ®Google Scholar
• Zhang Y, El-Sikhry H, Chaudhary KR, et al. (2009). Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 297:H37–H46
   PubMed Web of Science ®Google Scholar
• Zhang Y, Oltman CL, Lu T, et al. (2001). EET homologs potently dilate coronary microvessels and activate BK(Ca) channels. Am J Physiol Heart Circ Physiol 280:H2430–H2440
   PubMed Web of Science ®Google Scholar
• Zhao G, Wang J, Xu X, et al. (2012). Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-a-induced injury. J Lipid Res 53:456–466
   PubMed Web of Science ®Google Scholar
• Zhao X, Quigley JE, Yuan J, et al. (2006). PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats. Am J Physiol Heart Circ Physiol 290:H2187–H2195
   PubMed Web of Science ®Google Scholar
• Zhao Z, Geng J, Ge Z, et al. (2009). Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells. Mol Cell Biochem 322:171–178
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang W, Geng J, et al. (2010). Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation. J Cell Biochem 109:653–662
   PubMed Web of Science ®Google Scholar
• Zhu D, Bousamra M 2nd Zeldin DC, et al. (2000). Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 278:L335–L343
   PubMed Web of Science ®Google Scholar
• Zordoky BN, Aboutabl ME, El-Kadi AO. (2008). Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab Dispos 36:2277–2286
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. (2007). H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. J Pharmacol Toxicol Methods 56:317–322
   PubMedGoogle Scholar
• Zordoky BN, El-Kadi AO. (2008). Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure. Curr Drug Metab 9:122–128
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. (2010). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and beta-naphthoflavone induce cellular hypertrophy in H9c2 cells by an aryl hydrocarbon receptor-dependant mechanism. Toxicol In Vitro 24:863–871
   PubMed Web of Science ®Google Scholar
• Zou AP, Fleming JT, Falck JR, et al. (1996). 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 270:R228–R237
   PubMed Web of Science ®Google Scholar